TRANSCODE THERAPEUTICS INC (RNAZ)

US89357L3033 - Common Stock

3.49  -0.15 (-4.12%)

Premarket: 3.45 -0.04 (-1.15%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
14.63M19.42M18.63M6.15M726.60K
Research and Development
9.43M12.26M10.23M2.75M284.50K
Selling, General, and Administrative Expenses
5.20M7.16M8.40M3.40M442.10K
Operating Income
-14.63M-19.42M-18.63M-6.15M-726.60K
Interest Income/Expense
-365.53K-50.60K-11.60K-961.40K-1.60M
Other Income/Expense
66.25K923.00K1.08M272.20K-14.90K
Income Before Taxes
-14.93M-18.55M-17.57M-6.84M-2.34M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-14.93M-18.55M-17.57M-6.84M-2.34M
EBITDA
-14.52M-19.30M-18.54M-6.11MN/A
 
Per Share Data
EPS Diluted Total Ops
-37.11-103.61-1.08K-651.75-221.12
Non GAAP EPS
-24.26N/AN/AN/AN/A
 
Statistics

All data in USD

Charts